PHARMACEUTICAL SUPPLY CHAIN RESILIENCE: LESSONS FROM RECENT GLOBAL CRISIS

Abstract

Global crises such as the COVID-19 pandemic, have revealed critical vulnerabilities within pharmaceutical
supply chains, underscoring the importance of building resilience to ensure continuous access to essential
medicines. This review examines the key elements that contribute to the strength and adaptability of
pharmaceutical supply networks, including supplier diversification, effective inventory management,
adherence to regulatory standards, and the use of advanced technologies. Supply chain disruptions caused
by natural disasters, geopolitical tensions, economic fluctuations, cyber threats, and operational challenges
such as reliance on single-source suppliers and just-in-time inventory practices further highlight the need
for robust strategies. Strengthening resilience involves thorough risk assessments, business continuity
planning, and effective communication among stakeholders. Implementing predictive analytics,
blockchain, and real-time monitoring systems can improve supply chain visibility, traceability, and
proactive decision-making. Lessons learned from recent crises stress the value of cross-sector collaboration,
strategic stockpiling, and ongoing process improvement. This review provides an in-depth analysis of
pharmaceutical supply chain resilience, offering practical insights and strategies to mitigate risks and
ensure reliable delivery of medicines during global emergencies.